GC Green Cross, Enters Contract Manufacturing Business for Pharmaceuticals

[Asia Economy Reporter Cho Hyun-ui] GC Green Cross is entering the pharmaceutical contract manufacturing organization (CMO) business.

GC Green Cross announced on the 13th that it signed a memorandum of understanding (MOU) for CMO business cooperation with DM Bio at the Ochang plant in Cheongju, Chungbuk on the 12th.

The two companies plan to continue comprehensive collaboration across the entire business, including the latest trends and technology exchange in the CMO industry.

GC Green Cross intends to use the integrated finished product building at the newly constructed Ochang plant as a forward base for expanding its CMO business. The integrated finished product building is a production facility that unifies previously dispersed finished product processes. It was designed from the planning stage with both in-house production items and CMO volumes in mind.

GC Green Cross and DM Bio have each established filling lines specialized for vials and prefilled syringes (PFS), respectively, and the two companies expect synergy through this business agreement.

Heo Eun-cheol, CEO of GC Green Cross, said, "Cooperation with DM Bio, which has the business infrastructure, will be a great help in starting and expanding the CMO business," adding, "I hope this agreement will become a co-growth model that leverages the strengths of both companies."

This content was produced with the assistance of AI translation services.